1.. INTRODUCTION
================

Although Inch plant \[*Callissia fragrans*(Lindl.) Woodson\] and Jojoba (*Simmondsia chinensis)*have a rich folkloric reputation as antiviral and antimicrobial plants, to the best of our knowledge, no previous scientific reports about their antiviral properties are available.

*C. fragrans* is a herbaceous plant with small white fragrant flowers and waxy leaves growing wild in Mexico. It has been cultivated as indoor ornamental plants in many countries for 100 years. Lately, there is an increasing interest in its medicinal properties in Eastern Europe. Its leaves are used for treatment of various skin diseases, burns and join disorders. *C. fragrans*leaves contain biologically active flavonoids, neutral glycol-and phospholipids and their fatty-acid compositions \[[@R1]\]. The medicinal properties of *C. fragrans*have not been studied yet.

*S. chinensis*is an arid perennial shrub indigenous to Arizona, California and Northwestern Mexico. It is also grown in Australia, Brazil, Argentina and some Middle East countries. Its flowers are small, greenish-yellow, with 5-6 sepals and no petals. It is grown in many countries for liquid wax, commonly mistaken for jojoba oil, extracted from its seeds. This liquid wax was used in folk remedies for renal colic, sunburn, chaffed skin, hair loss, headache, wounds, sore throat and as cosmetics \[[@R2]\]. The anti-inflammatory and antimicrobial properties of*S. chinensis* liquid wax have also been previously reported \[[@R3],[@R4]\]. Leaves of *S. chinensis*are used in folk medicine for the treatment of various skin diseases.

The chemical content of*S. chinensis* leaves is not well known because most of the studies focused on the chemical composition of its seeds which contain high tannins concentration \[[@R5]\].

Although acyclovir (ACV) and other nucleoside derivatives have been approved for therapeutic use against various members of the herpes viruses \[[@R6]\], the search for new effective anti-herpetic drugs is very important due to the following reasons: (a) development of anti-ACV resistant herpes viruses mutants \[[@R7]\], (b) side effects, such as nausea, vomiting and headache, rash and diarrhea, associated with the available drugs and (c) ACV is not highly effective in recurrent virus attacks \[[@R8]\].

In the present study we investigated the antiviral activity of both ethanol and aquatic leaf extracts of *C. fragrans*and *S. chinensis*and their purified fractions on various members of herpes family viruses; herpes simplex viruses type 1 and 2 (HSV-1, HSV-2) and varicella zoster virus (VZV), *in vitro.*

2.. MATERIALS AND METHODOLOGY
=============================

2.1.. Materials
---------------

*C. fragrans*and *S. chinensis* plants were obtained from nurseries and grown in a controlled greenhouse at the Ben Gurion University, Beer-Sheva, Israel.

ACV \[9-(2-hydroxyethoxymethyl) guanosine, Sigma\] was used as a positive control drug.

2.2.. Preparation of Ethanol and Aquatic Leaf Extracts and Separation of Extracts
---------------------------------------------------------------------------------

Ethanol and aquatic extracts were prepared from leaves of *C. fragrans*and *S. chinensis*. Plant tissues were crushed, incubated at room temperature for 48 hours in appropriate solvent, centrifuged at 2000 rpm for 10 min and the supernatant was evaporated by lyophilizer. The pellet was dissolved in minimal amount of 95% ethanol (0.5 ml) or water and diluted with water to final concentration of 10mg/ml. The extracts were sterilized by filtration and diluted with medium containing 2% Newborn calf serum (NBCS) to the appropriate concentrations.

Extracts were separated into different fractions using reverse phase column with rising methanol gradient: 0%, 20%, 40%, 60%, 80% and 100% (RP-C18 sepack).

2.3.. Cells and Viruses
-----------------------

African green monkey kidney (Vero) cells were purchased from the American Type Culture Collection (ATCC), Rockville, MD, USA. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS), 1% glutamine, 50 U/ml penicillin, 50 µg/ml streptomycin and incubated at 37° C in a humidified air containing 5% CO~2~. HSV-1, HSV-2 and VZV were propagated in Vero cells and their concentration was estimated by a standard plaque assay \[[@R9]\].

2.4.. Cytotoxicity Examination
------------------------------

Vero cells were treated with various concentrations of leaf extracts and the toxicity of the extracts was tested by three different methods:

1.  [Direct count]{.ul} The cells were counted by Neubauer hemacytometer indicating their replication rate.

2.  [Morphological changes]{.ul} were observed daily by optical inverted microscope.

3.  [MTT assay]{.ul} was performed as previously described \[[@R10]\].

2.5.. Antiviral Activity Examination
------------------------------------

The antiviral activity of the tested plant extracts and their fractions was evaluated by plaque assay and cytopathic effect (CPE) development \[[@R9]\].

In order to elucidate the antiviral mechanism of action of the tested extracts, the cells were treated with the appropriate doses of the extract for different periods of time at/ and or after infection with virus as follow:

a.  Treatment only at the time of infection- The appropriate dose of the extract was added to the cells at the time of infection. At the end of 2h infection the medium containing the extract was removed and replaced with fresh medium without extract up to the end of the experiment.

b.  Treatment at the time and after infection- The appropriate dose of the extract was added to the cells at the time of infection. At the end of 2h infection the medium containing the extract was removed and replaced with fresh medium containing the extract up to the end of the experiment.

c.  Treatment only at the end of infection- The cells were infected with the virus without treatment with the extract. At the end of 2h infection the medium was removed and replaced with fresh medium containing the appropriate dose of the extract up to the end of the experiment.

For examining possible interactions between the examined extracts and the cells, Vero cells were incubated in a medium containing the appropriate dose of the extract at 37°C for 2h, washed 3 times with saline and infected with the virus without further treatment with the leaf extract. For elucidating possible direct effect of the tested extracts on the infectivity of the virus particles, the extracts were incubated with the virus at 4ºC for different periods of time (15, 30 and 45 minutes). Then these mixtures were diluted with fresh medium and cell monolayers were infected with the diluted mixture.

The selectivity index (SI) was determined as CC~50~/EC~50~, where CC~50~ is the concentration found to cause 50% toxicity and EC~50~is concentration found to provide 50% prevention of plaque forming units (PFU).

2.6.. Statistical Analysis
--------------------------

All data were analyzed using Statistica for Windows software (StatSoft, Inc., Tulsa, Oklahoma), and P\<0.05 was chosen as the minimal acceptable level of significance.

3.. RESULTS
===========

3.1.. Cytotoxicity Examination
------------------------------

Vero cells were treated with the extracts at different concentrations (1-1500 µg/ml) for 4 days. Our results (Table **[1](#T1){ref-type="table"}**) show that both ethanol and aquatic extracts of*C. fragrans* didn\'t show any toxicity at concentrations ≤ 500 µg/ml, however, the aquatic extracts were less toxic than ethanol extracts. Both ethanol and aquatic of *S. chinensis* leaf extracts had a high cytotoxicity.

3.2.. Antiviral Activity Examination
------------------------------------

Vero cell monolayers were treated with increasing extract concentrations at the time of infection with 0.1 m.o.i. of HSV-1, HSV-2 or VZV. The treatment was terminated immediately post-infection (p.i) and the antiviral activity was evaluated by plaque assay.

Fig. (**[1](#F1){ref-type="fig"}**) demonstrates that the best results were obtained with ethanol extract of *C. fragrans*which showed the highest SI against HSV-1, HSV-2 and HSV-2 mutant (resistant to ACV), while it was ineffective against VZV. The ethanol extract of *S. chinensis*was not effective against all tested viruses due to its high toxicity. Therefore, it was not included in the further experiments with the extracts. Although SI of all used extracts were lower than that of ACV (Table **[3](#T3){ref-type="table"}**), these extracts nevertheless inhibited ACV-resistant HSV-2 mutant (Fig. **[1](#F1){ref-type="fig"}**).

3.3.. Mechanism of Action
-------------------------

Vero cells were infected with 0.1 m.o.i. of the examined herpes viruses and treated with 100 µg/ml of *C. fragrans*leaf extracts or 50 µg/ml of *S. chinesis*aquatic extract for various periods of time before, at, or after infection. When the cells were treated with the extracts only at the time of infection or both at the time and post-infection, the inhibition of all examined viruses was the highest (Table **[2](#T2){ref-type="table"}**). It seems that pre-incubation of the cells with the extracts (without further treatment) had no significant effect on the development of infection induced by all examined viruses (p\>0.1). However, treatment of the infected cells only p. i. caused partial inhibition of the viral infection (Table **[2](#T2){ref-type="table"}**).

Plant extracts are thought to exert their inhibitory action at a very early stage in the viral infection cycle i.e. virus adsorption onto and/or penetration into the host cell.

In order to examine possible interactions between viral particles and leaf extracts, the tested viruses were pre-incubated with the extracts, then these mixtures were diluted with a fresh medium to antivirally inactive concentrations of the extract. The diluted mixtures were used for infecting Vero cell monolayers. Our results showed considerable inhibition of plaque formation by the highly diluted extracts mixtures (Fig. **[2](#F2){ref-type="fig"}**). Most significant inhibition of the tested viruses was obtained after 30-45 minutes of incubation with the different extracts (Fig. **[2](#F2){ref-type="fig"}**).

3.4.. Effect of Extract Removal on CPE Development
--------------------------------------------------

Vero cells were infected with 0.5 m.o.i. of HSV-1 and treated with 500 µg/ml ethanol extract of *C. fragrans*immediately post infection. At different periods of time p.i. (1, 3, 10 days) the treatment with the extract was terminated. It can be seen that continuous treatment almost prevented the CPE development of all examined viruses (about 95% prevention) during the period of experiment (Fig. **[3](#F3){ref-type="fig"}**). However, when the leaf extract was removed even at 10 days p.i., a moderate increase in CPE development was observed (Fig. **[3](#F3){ref-type="fig"}**). Similar results were obtained with other plant extracts and other viruses (data not shown). The continuous presence of the leaf extracts in the cell culture medium is apparently essential for continuous protection of Vero cells against viral CPE development.

3.5.. Antiviral Activity of Fractions of *C. fragrans* and *S. chinensi* Extracts
---------------------------------------------------------------------------------

Cytotoxicity and antiviral activity of several fractions from the plant extracts were examined. The obtained results (Table **[3](#T3){ref-type="table"}**) showed that for *C. fragrans*, fraction 60%-MeOH of the ethanol extract strongly inhibited HSV-1 and HSV-2 but only slightly VZV, whereas fraction 20%-MeOH of the aquatic extract significantly inhibited all tested viruses. All fractions of both ethanol and aquatic extracts of *S. chinensis* showed relatively high SI but the 60%-MeOH fraction of the ethanol extract had the highest SI (Table **[4](#T4){ref-type="table"}**).

4.. DISCUSSION
==============

The extracts tested in this study may therefore provide a potential source of effective anti-herpetic compounds which seem less toxic than ACV and effective against HSV mutants resistant to ACV, whose prevalence has increased to 7% for last 20 years \[[@R11]\].

In fact, the antiviral activity of the various examined extracts against the different viruses was significantly lower than that of ACV, as presented by their SI values (Fig. **[1](#F1){ref-type="fig"}** and Table **[4](#T4){ref-type="table"}**).

Our results suggest, in agreement with previous findings \[[@R12], [@R13]\], that the examined plant extracts exert their antiherpetic effect mainly by direct interaction with the virus particles and by blocking the virus access to the host cells. The significant inhibition of the tested herpes viruses as a result of direct effect of the extracts (Fig. **[2](#F2){ref-type="fig"}**) suggests strong interactions between the extract and the herpetic viruses. This effect could be caused either by a strong or maybe irreversible interaction between the virus and the extract, the effect being maintained after several serial dilutions, or by a direct inactivation of the virus. Our results didn\'t show any inhibition of the viral infection in plant-extract pretreated cell cultures (Table **[2](#T2){ref-type="table"}**). This could be explained by either a weak and reversible interaction or completely miss-interaction between the extract and the cell membrane. It is important also to mention that treatment of the infected cells only p.i. with the extracts caused partial inhibition of the viral infection (Table **[2](#T2){ref-type="table"}**). This inhibition could be a result of preventing re-infections with the newly produced viruses by the extracts. All the above mentioned results do not exclude the possibility of inhibitory effect of these extracts on additional steps during the replication cycle of the examined viruses. Our ongoing study is examining also these possibilities.

However, separation of these extracts into different fractions dramatically improved their SI mainly due to the decreased cytotoxicity of these fractions compared to the crude extracts (Tables **[3](#T3){ref-type="table"}** and **[4](#T4){ref-type="table"}** ). The obtained SI of all tested crude extracts and fractions for HSV-1 were significantly higher than those mentioned in the current literature \[[@R14], [@R15]\].

It is worthwhile highlighting the impressive increase in SI values of *S. chinensi* fractions compared to their crude extracts. Best SI values were obtained with fraction 60%-MeOH of the different extracts. It seems according our experience that this fraction is rich with polyphenols. In addition, it can be seen from the results presented in Table **[4](#T4){ref-type="table"}** that most of *S. chinensis*fractions show antiviral activity, which might indicate for the presence of various components in the extract that have antiviral activity. As we know each fraction still composes different substances.

Additional investigation is required for further isolation and identification of the plant antiviral agents from effective fractions.

5.. CONCLUSION
==============

1.  The *C. fragrans* ethanol extract effectively inhibited the infection of Vero cells by HSV-1, HSV-2 *in vitro*, while its aquatic extract inhibited only VZV.

2.  *S. chinensis* leaf extracts strongly inhibited all studied viruses, but their high cytotoxicity led to lower SI values.

3.  In general, purified fractions of the tested plants had low cytotoxicity and very high SI.

4.  The highest antiviral activity of the extracts against all tested viruses was obtained when the cells were treated with the extracts at the time and post infection.

5.  Strong interaction between the virus and the extracts is suggested.
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![Selectivity index (SI) of plant extracts against HSV-1, HSV-2, VZV and HSV-2 mutant (resistant to ACV). SI was determined as CC~50~ /EC~50~. Values are means ± SD (n=5).](TOVJ-4-57_F1){#F1}

![Effect of pre-incubation of leaf extracts with HSV-1, HSV-2 and VZV on virus infectivity. (**A**) 1000 µg/ml of *C. fragrans* ethanol leaf extract, (**B**) 1000 µg/ml of *C. fragrans* aquatic leaf extracts and (**C**) 100 µg/ml of *S. chinensis* aquatic leaf extracts were incubated with the infecting virus (5m.o.i.) at 4°C for different periods of time (15, 30 and 45 minutes). Every mixture was diluted 104 times with fresh medium and the cells were infected with the diluted mixture. PFU were evaluated by the standard plaque assay and presented as means ± SD (n=5).](TOVJ-4-57_F2){#F2}

![Effect of leaf extracts removal on the development of herpes viruses cytophatic effect (CPE). Vero cells were infected with 0.05 m.o.i. of HSV-1and treated with 500 µg/ml of *C. fragrans* ethanol leaf extract at the end of infection. The treatment was terminated at 1, 3 or 10 days p. i. CPE development was evaluated every 24 h by inverted microscopy and expressed as the percentage of damaged cells in the culture. Data are means ± SD of three independent experiments.](TOVJ-4-57_F3){#F3}

###### 

Toxicity of Leaf Extracts at Different Concentrations

  Viability[1](#T1FN1){ref-type="table-fn"} (% of Control)   Cell Number[2](#T1FN2){ref-type="table-fn"} (% of Control)   Concentration (µg/ml)   Extract Type   Plant
  ---------------------------------------------------------- ------------------------------------------------------------ ----------------------- -------------- --------------------
  99.9±3.09                                                  102.5±0.36                                                   10                      Ethanol        ***C. fragrans***
  98.8±3.01                                                  100.2±1.21                                                   100                                    
  97.1±3.07                                                  100.6±0.46                                                   500                                    
  72.6±4.90                                                  65.3±3.81                                                    1000                                   
  33.9±2.98                                                  34.3±3.18                                                    1500                                   
  101.8±3.55                                                 101.1±2.45                                                   10                      Aquatic        
  101.5±3.48                                                 101.1±1.78                                                   100                                    
  100.7±3.45                                                 100.2±2.36                                                   500                                    
  100.8±2.78                                                 100.7±2.61                                                   1000                                   
  53.3±3.25                                                  54.3±2.28                                                    1500                                   
  99.5±2.09                                                  96.0±0.81                                                    10                      Ethanol        ***S. chinensis***
  98.7±3.13                                                  98.3±2.63                                                    100                                    
  33.6±1.27                                                  36.9±1.27                                                    500                                    
  102.6±4.56                                                 101.1±2.15                                                   10                      Aquatic        
  101.2±3.78                                                 100.5±2.98                                                   50                                     
  43.6±3.45                                                  46.8±2.17                                                    100                                    

Average of 3 cultures ± SD. Viability of cells was evaluated by MTT assay after 4 days of treatment with the plant extract.

Average of 3 cultures ± SD, after 4 days of treatment.

###### 

Effect of Time of Leaf Extract Addition on Herpes Viruses Infection

  PFU (% of Control)   Virus (0.1 m.o.i.)   Leaf Extract                         
  -------------------- -------------------- -------------- ------------- ------- ----------------------------------
  90.2±2.45            99.4±3.22            97.3±2.67      100.1±1.36    HSV-1   *C. fragrans*(aquatic extract)
  92.0±1.65            99.6±2.78            98.0±3.07      99\. 6±2.24   HSV-2   
  1.0±0.32             16.52±0.87           1.4±0.75       98.7±2.87     VZV     
  20.0±0.8             65.22±3.14           .9±1.2 27      100±1.39      HSV-1   *C. fragrans* (ethanol extract)
  12\. 6±3.12          59.25±2.56           23.5±2.25      101.1±2.14    HSV-2   
  76.3±4.53            98.25±1.94           84.2±2.89      100.2±1.52    VZV     
  3.4±0.98             42.85±2.5            11.4±3.2       3.6±2.15      HSV-1   *S. chinensi*s (aquatic extract)
  2.1±0.65             38.25±2.14           9\. 6±2.07     94.1±1.89     HSV-2   
  7.2±1.98             48.56±4.02           16.3±1.58      95.3±3.08     VZV     

Vero cell monolayers were treated with 100 µg/ml of the *C. fragrans*extracts and 50 µg/ml of the *S. chinensis*aquatic extract before, at or after infection with 0.1m.o.i. of HSV-1, HSV-2 or VZV. Antiviral activity was evaluated by plaque assay. Values are presented as means ± SD (n=5).

###### 

Antiviral Activity of Crude Extracts and Fractions of *C. fragrans*Against Herpetic Viruses

  Extract/Fraction                    CC~50~ (µg/ml)   HSV-1      HSV-2     VZV                            
  ----------------------------------- ---------------- ---------- --------- ---------- -------- ---------- ---------
  ***C. fragrans,*Ethanol Extract**                                                                        
  Crude extract                       1100             16.5       66.6      15         73.3     800        1.4
  0%-MeOH                             \>1000           Inactive   \-        Inactive   \-       Inactive   \-
  20%-MeOH                            \>1000           40         \>25      35         \>28.6   21         \>47.6
  40%-MeOH                            \>1000           30         \>33.3    28         \>35.7   40         \>25
  60%-MeOH                            \>1000           8          \>125     5          \>200    32         \>31.3
  80%-MeOH                            \>1000           Inactive   \-        Inactive   \-       84         \>11.9
  100%-MeOH                           \>1000           35         \>28.6    32         \>31.2   100        \>10
  ***C. fragrans,*Aquatic Extract**                                                                        
  Crude extract                       1550             500        3.1       650        2.4      17         91.2
  0%-MeOH                             \>1000           Inactive   \-        Inactive   \-       Inactive   \-
  20%-MeOH                            \>1000           2          \>500     5          \>200    7          \>142.8
  40%-MeOH                            \>1000           15         \>66.7    20         \>50     5          \>200
  60%-MeOH                            \>1000           40         \>25      45         \>22.2   70         \>14.3
  80%-MeOH                            \>1000           Inactive   \-        Inactive   \-       20         \>50
  100%-MeOH                           \>1000           9.5        \>105.3   12         \>83.3   Inactive   \-
  ACV                                 70               0.1        700       0.25       280      0.15       466.7

Vero cell monolayers were treated with different doses of the *C. fragrans*extracts and their purified fractions at the time of infection. The EC~50~ values of these examined products were determined and the SI values were calculated. Antiviral activity was evaluated by plaque assay.

###### 

Antiviral Activity of Crude Extracts and Fractions of *S. chinensis* and ACV Against Herpetic Viruses

  Material                              CC~50~ (µg/ml )   HSV-1   HSV-2     VZV                     
  ------------------------------------- ----------------- ------- --------- ------ --------- ------ ---------
  ***S. chinensis*, Ethanol Extract**                                                               
  Crude extract                         250               50      5         45     5.5       55     4.5
  0%-MeOH                               500               9.5     52.6      8      62.5      5      100
  20%-MeOH                              450               8       56.2      7.5    62.3      4      112.5
  40%-MeOH                              400               5.5     72.72     5      80        4.5    88.9
  60%-MeOH                              \>1000            9       \>111.1   9      \>111.1   4      \>250
  80%-MeOH                              70                4.5     15.6      4      17.5      8.5    8.2
  100%-MeOH                             60                6       10        5.5    10.9      6.5    9.2
  ***S. chinensis*, Aquatic Extract**                                                               
  Crude extract                         95                10      9.5       10     9.5       14     6.78
  0%-MeOH                               50                3       16.7      3.5    14.3      8      6.2
  20%-MeOH                              400               5.5     72.7      5.5    72.7      9      44.4
  40%-MeOH                              500               2.5     200       2.5    200       8.5    58.8
  60%-MeOH                              500               2.2     227.3     2.5    200       3.5    142.9
  80%-MeOH                              \>1000            7       \>142.8   7.5    \>62.3    3      \>333.3
  100%-MeOH                             \>1000            5       \>200     5      \>200     2      \>200
  ACV                                   70                0.1     700       0.25   280       0.15   466.7

Vero cell monolayers were treated with different doses of the *S. chinensis*extracts and their purified fractions at the time of infection. The EC~50~ values of these examined products were determined and the SI values were calculated. Antiviral activity was evaluated by plaque assay.
